{
    "Project Title": "ACADEMIC: ADT + Docetaxel vs ADT + Abiraterone",
    "Sponsor": "Huntsman Cancer Institute",
    "Study Number": "HCI-18-GU-11",
    "Protocol Version and Date": "Version 2: 13MAR2019",
    "Study Title": "A Randomized Phase II Clinical Trial of ADT Combined with Abiraterone or Docetaxel in Metastatic Hormone Sensitive Prostate Cancer.",
    "Phase": "Phase II",
    "Therapeutic Area": "Metastatic Hormone Sensitive Prostate Cancer",
    "Number of Patients": "89",
    "Number of Sites": "Up to 8 (including Huntsman Cancer Institute and 7 additional centers)",
    "Indication": "Metastatic Hormone Sensitive Prostate Cancer",
    "Duration of Treatment": "Treatment for approximately 18 months; study enrollment expected to take 24 months",
    "Schedule of Assessments": "Not Available",
    "questionnaires": [
        {
            "longName": "Functional Assessment of Cancer Therapy - Prostate (FACT-P)",
            "shortName": "FACT-P",
            "type": "PRO",
            "questionnaireSchedule": "Baseline and Month 12"
        },
        {
            "longName": "Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-NTX)",
            "shortName": "FACT/GOG-NTX",
            "type": "PRO",
            "questionnaireSchedule": "Months 0, 3, 6, 9, 12, 18",
            "questionnaireTiming": [
                "M3",
                "M6",
                "M9",
                "M12",
                "M18"
            ]
        },
        {
            "longName": "PROMIS Fatigue",
            "shortName": "PROMIS Fatigue",
            "type": "PRO",
            "questionnaireSchedule": "Month 0, 3, 6, 9, 12, 18",
            "questionnaireTiming": [
                "M3",
                "M6",
                "M9",
                "M12",
                "M18"
            ]
        },
        {
            "longName": "Overall Treatment Utility (OTU)",
            "shortName": "OTU",
            "type": "ClinRO",
            "questionnaireSchedule": "Month 3"
        },
        {
            "longName": "Was It Worth It (WIWI)",
            "shortName": "WIWI",
            "type": "PREM",
            "questionnaireSchedule": "Month 18 (or progression visit)"
        },
        {
            "longName": "End of Study Evaluation Form",
            "shortName": "End of Study Evaluation",
            "type": "PREM",
            "questionnaireSchedule": "Month 18 (or progression visit)"
        },
        {
            "longName": "Extent of Metastases Form",
            "shortName": "Extent of Metastases",
            "type": "None",
            "questionnaireSchedule": "Screening",
            "questionnaireTiming": [
                "Screening1"
            ]
        }
    ]
}